Health Technology Assessment and Health Policy-Making in Europe – Current Status, Challenges and Potential

Public Health ◽  
2010 ◽  
Vol 124 (5) ◽  
pp. 298-299
Author(s):  
Harpreet S. Kohli
2005 ◽  
Vol 21 (3) ◽  
pp. 312-318 ◽  
Author(s):  
Bjørn Hofmann

Objectives: Although ethics has been on the agenda in health technology assessment (HTA) since its inception, the integration of moral issues is still not standard and is performed in a vast variety of ways. Therefore, there is a need for a procedure for integrating moral issues in HTA.Methods: Literature review of existing approaches together with application of various theories in moral philosophy and axiology.Results: The article develops a set of questions that addresses a wide range of moral issues related to the assessment and implementation of health technology. The issues include general moral issues and moral issues related to stakeholders, methodology, characteristics of technology, and to the HTA process itself. The questions form a kind of checklist for use in HTAs.Conclusions: The presented approach for integrating moral issues in HTA has a broad theoretical foundation and has shown to be useful in practice. Integrating ethical issues in HTAs can be of great importance with respect to the dissemination of HTA results and in efficient health policy making.


2017 ◽  
Vol 2 (1) ◽  
pp. 1-3 ◽  
Author(s):  
Shankar Prinja ◽  
Laura E. Downey ◽  
Vijay K. Gauba ◽  
Soumya Swaminathan

Evaluation ◽  
2008 ◽  
Vol 14 (3) ◽  
pp. 295-321 ◽  
Author(s):  
Pascale Lehoux ◽  
Myriam Hivon ◽  
Jean-Louis Denis ◽  
Stéphanie Tailliez

Author(s):  
Wija Oortwijn ◽  
Gert Jan van der Wilt

The Special Interest Group on Ethics and HTA (health technology assessment) has invited two renowned philosophers, Norman Daniels from Harvard University and Henry Richardson from Georgetown University to reflect on the role of HTA in healthcare policy making. Both acknowledge its importance, but at the same time warn against a too mechanistic deployment of HTA. In their view, the relevance of HTA to healthcare policy making would considerably be enhanced if it were subsumed within a broader deliberative framework. Why should this be so? What is there to deliberate on, who should do the deliberating, where and when, and how does this relate to the more technical elements of HTA such as evidence synthesis and economic modeling?


EP Europace ◽  
2011 ◽  
Vol 13 (suppl 2) ◽  
pp. ii49-ii53 ◽  
Author(s):  
G. Fattore ◽  
N. Maniadakis ◽  
L. G. Mantovani ◽  
G. Boriani

Sign in / Sign up

Export Citation Format

Share Document